TTY Biopharm Company Limited (TPEX:4105)
Taiwan
· Delayed Price · Currency is TWD 82.40
+1.00 (1.23%)
Mar 10, 2026, 12:57 PM CST
TTY Biopharm Company Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 20,240 | 18,102 | 19,991 | 20,737 | 17,107 | 17,057 | Upgrade
|
| Market Cap Growth | 6.54% | -9.45% | -3.60% | 21.22% | 0.29% | -16.75% | Upgrade
|
| Enterprise Value | 20,254 | 18,292 | 20,061 | 20,686 | 16,707 | 17,498 | Upgrade
|
| Last Close Price | 81.40 | 68.90 | 72.83 | 72.32 | 57.19 | 54.16 | Upgrade
|
| PE Ratio | 11.32 | 12.49 | 17.72 | 18.95 | 20.56 | 18.46 | Upgrade
|
| Forward PE | 13.73 | 12.86 | 14.81 | 17.45 | 16.54 | 13.10 | Upgrade
|
| PS Ratio | 3.14 | 3.07 | 3.63 | 4.10 | 3.77 | 4.04 | Upgrade
|
| PB Ratio | 2.51 | 2.41 | 3.07 | 3.33 | 2.97 | 2.81 | Upgrade
|
| P/TBV Ratio | 2.97 | 2.84 | 3.46 | 3.84 | 3.39 | 3.21 | Upgrade
|
| P/FCF Ratio | 12.14 | 14.79 | 19.85 | 18.12 | 14.30 | 47.61 | Upgrade
|
| P/OCF Ratio | 11.49 | 13.42 | 18.42 | 16.78 | 13.62 | 32.41 | Upgrade
|
| EV/Sales Ratio | 3.11 | 3.10 | 3.64 | 4.09 | 3.68 | 4.14 | Upgrade
|
| EV/EBITDA Ratio | 8.82 | 11.52 | 12.81 | 14.69 | 12.82 | 15.75 | Upgrade
|
| EV/EBIT Ratio | 9.66 | 13.12 | 14.62 | 16.85 | 14.65 | 18.28 | Upgrade
|
| EV/FCF Ratio | 12.15 | 14.94 | 19.92 | 18.08 | 13.97 | 48.85 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.23 | 0.29 | 0.29 | 0.37 | 0.35 | Upgrade
|
| Debt / EBITDA Ratio | 1.06 | 1.08 | 1.19 | 1.28 | 1.65 | 1.93 | Upgrade
|
| Debt / FCF Ratio | 1.22 | 1.40 | 1.85 | 1.58 | 1.79 | 5.98 | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.18 | -0.15 | -0.14 | -0.08 | -0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.41 | -0.86 | -0.61 | -0.62 | -0.34 | -0.38 | Upgrade
|
| Net Debt / FCF Ratio | -0.48 | -1.12 | -0.95 | -0.77 | -0.38 | -1.18 | Upgrade
|
| Asset Turnover | 0.59 | 0.57 | 0.56 | 0.54 | 0.49 | 0.45 | Upgrade
|
| Inventory Turnover | 1.99 | 2.10 | 2.08 | 2.05 | 1.71 | 1.64 | Upgrade
|
| Quick Ratio | 1.45 | 1.56 | 1.62 | 1.35 | 1.23 | 1.42 | Upgrade
|
| Current Ratio | 2.01 | 2.02 | 2.08 | 1.73 | 1.56 | 1.88 | Upgrade
|
| Return on Equity (ROE) | 25.60% | 21.68% | 17.56% | 18.38% | 13.89% | 15.98% | Upgrade
|
| Return on Assets (ROA) | 9.56% | 8.40% | 8.81% | 8.12% | 7.64% | 6.33% | Upgrade
|
| Return on Invested Capital (ROIC) | 20.19% | 19.22% | 19.84% | 18.02% | 15.73% | 14.37% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.20% | 17.40% | 18.80% | 18.40% | 18.30% | 14.10% | Upgrade
|
| Earnings Yield | 7.70% | 8.01% | 5.64% | 5.28% | 4.86% | 5.42% | Upgrade
|
| FCF Yield | 8.24% | 6.76% | 5.04% | 5.52% | 6.99% | 2.10% | Upgrade
|
| Dividend Yield | 5.04% | 6.09% | 4.81% | 4.70% | 5.24% | 7.39% | Upgrade
|
| Payout Ratio | 66.98% | 60.04% | 74.91% | 68.16% | 119.56% | 107.62% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.04% | -0.03% | 0.02% | 0.00% | -0.03% | Upgrade
|
| Total Shareholder Return | 5.02% | 6.06% | 4.78% | 4.72% | 5.25% | 7.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.